NYSE - Delayed Quote • USD
Integer Holdings Corporation (ITGR)
At close: April 18 at 4:00 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 7 | 7 | 8 | 7 |
Avg. Estimate | 1.11 | 1.26 | 5.31 | 6.04 |
Low Estimate | 1 | 1.14 | 5.23 | 5.97 |
High Estimate | 1.16 | 1.31 | 5.37 | 6.11 |
Year Ago EPS | 0.87 | 1.14 | 4.67 | 5.31 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 7 | 7 | 7 | 6 |
Avg. Estimate | 412.82M | 438.16M | 1.76B | 1.89B |
Low Estimate | 407.12M | 422.5M | 1.75B | 1.86B |
High Estimate | 414.77M | 443.82M | 1.77B | 1.92B |
Year Ago Sales | 367.9M | -- | 1.6B | 1.76B |
Sales Growth (year/est) | 12.20% | -- | 10.20% | 7.50% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 0.83 | 1 | 1.1 | 1.33 |
EPS Actual | 0.87 | 1.14 | 1.27 | 1.39 |
Difference | 0.04 | 0.14 | 0.17 | 0.06 |
Surprise % | 4.80% | 14.00% | 15.50% | 4.50% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 1.11 | 1.26 | 5.31 | 6.04 |
7 Days Ago | 1.11 | 1.25 | 5.3 | 6.02 |
30 Days Ago | 1.12 | 1.25 | 5.3 | 6.02 |
60 Days Ago | 1.17 | 1.35 | 5.43 | 6.13 |
90 Days Ago | 1.17 | 1.37 | 5.41 | 6.17 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | 1 | 1 | 1 | -- |
Growth Estimates
CURRENCY IN USD | ITGR | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 27.60% | -- | -- | 0.80% |
Next Qtr. | 10.50% | -- | -- | 9.60% |
Current Year | 13.70% | -- | -- | 4.50% |
Next Year | 13.70% | -- | -- | 13.30% |
Next 5 Years (per annum) | 13.60% | -- | -- | 11.09% |
Past 5 Years (per annum) | 3.65% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
Earnings
Upgrades & Downgrades
Upgrade | B of A Securities: Neutral to Buy | 4/15/2024 |
Maintains | Keybanc: Overweight to Overweight | 4/9/2024 |
Maintains | Benchmark: Buy to Buy | 3/28/2024 |
Initiated | CL King: Buy | 3/14/2024 |
Maintains | Keybanc: Overweight to Overweight | 2/16/2024 |
Initiated | Keybanc: Overweight | 2/6/2024 |
Related Tickers
LIVN LivaNova PLC
52.76
+1.72%
CNMD CONMED Corporation
71.08
-2.31%
INSP Inspire Medical Systems, Inc.
241.15
-0.97%
MASI Masimo Corporation
135.92
-0.51%
GMED Globus Medical, Inc.
50.75
-0.88%
NVRO Nevro Corp.
12.32
+0.24%
PEN Penumbra, Inc.
201.84
-3.28%
IART Integra LifeSciences Holdings Corporation
31.63
-0.97%
OFIX Orthofix Medical Inc.
13.02
+0.15%
UFPT UFP Technologies, Inc.
217.74
-3.50%